niels van der donk on Instagram: “some 3D sculpts for @yonk.online based on @sander_ettema his illustrations (:”
Niels Van De Donk - VUmc | LinkedIn
JNCCN 360 - MM - Videos
Myeloomcellen efficiënt gedood met bispecifieke antilichamen - Oncologie.nu
Niels van de Donk, MD, PhD, Discusses MajesTEC-1 Follow-Up Data on Teclistamab in Multiple Myeloma
Niels Van de Donk | ASCO 2018 | What to do when antibodies fail in MM
Dr. Niels van de Donk
Niels van de Donk | Videos & Research | VJHemOnc
ASH 2014 Highlights webinar on 27th January - Myeloma Patients Europe
Niels Van De Donk - VUmc | LinkedIn
Dr. Niels Van de Donk Interprets the Latest Research Progress on CAR-T Treatment for RRMM - MediaMedic
Efficacy of Teclistimab versus current treatments in patients with triple-class exposed relapsed refractory myeloma
International Myeloma Foundation on X: "#ASH23: Dr. Niels van de Donk discusses the safety and clinical activity of 3 different doses of iberdomide as maintenance treatment post-transplant in newly diagnosed #myeloma patients.
Niels Van De Donk - VUmc | LinkedIn
EHA21 - Niels van de Donk
Niels van de Donk | Videos & Research | VJHemOnc
Niels van de Donk, MD, PhD, on MajesTEC-1 Follow-Up Data on Teclistamab in Multiple Myeloma | Blood Cancers Today
Niels van Donk - UK EuroBV Ltd. | LinkedIn
Niels van de Donk wint hematologieprijs - Hematon
Niels van de Donk
Niels Van De Donk - VUmc | LinkedIn
Niels van de Donk | Videos & Research | VJHemOnc
Niels van de Donk | Videos & Research | VJHemOnc
